Immunic raised funds to support Phase 3 clinical trials of vidofludimus calcium for MS and transition into a commercial-stage company.

A collaboration will test whether changes in a person’s voice can help detect multiple sclerosis, potentially enabling a faster diagnosis.

After struggling during seasons when MS took center stage, columnist Ahna Crum is enjoying the quieter days where it's only ...

With this year's Read-a-Thon for kids, running through March, MS Canada hopes to raise CA$65,000 to support research and community programs.

Some MS diets may help lower inflammation marker levels, but evidence from clinical trials remains limited, according to a new review paper.

A type of immune cell targeting the Epstein-Barr virus may play a key role in driving multiple sclerosis (MS), a study found.

TG Therapeutics is gearing up for a new clinical trial, dubbed ULTIMATE, to test Briumvi in children and adolescents with ...

People with MS who engage in more physical activity tend to have less severe physical and cognitive disability, a study demonstrated.

When an insurance denial blocks guest writer Denise Schnieders from getting an MS disease activity test, she decides to fight back.

Columnist Ben Hofmeister has just completed his third overnight sleep study in three years as part of an effort to control sleep apnea.

New clinical trial data suggest vidofludimus calcium can target key mechanisms underlying progressive multiple sclerosis.